Concepedia

Publication | Open Access

Usefulness of <sup>18</sup>F‐fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and treatment response of neoadjuvant therapy for pancreatic ductal adenocarcinoma

37

Citations

26

References

2020

Year

Abstract

PERCIST was more accurate in determining NAT's therapeutic effects for PDAC than RECIST. MTV reduction rates were independent prognostic factors for PDAC.

References

YearCitations

Page 1